Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2007 May 16;21(3):188–192. doi: 10.1002/jcla.20176

Turbidimetric carbamazepine immunoassay on the ADVIA® 1650 and 2400 analyzers is free from interference of antihistamine drugs hydroxyzine and cetirizine

Pradip Datta 1, Amitava Dasgupta 2,
PMCID: PMC6649095  PMID: 17506478

Abstract

A recent report indicates that hydroxyzine and its active metabolite cetirizine interfere with the particle‐enhanced turbidimetric inhibition immunoassay (PENTINA) carbamazepine assay. We studied potential interference of hydroxyzine and cetirizine with the turbidimetric carbamazepine immunoassay on ADVIA® 1650 and ADVIA 2400 (Bayer Diagnostics, Tarrytown, NY) analyzers. Aliquots of drug‐free serum pools were supplemented with various concentrations of hydroxyzine and cetirizine representing therapeutic, moderate toxic, as well as very toxic concentrations. These samples were assayed by the turbidimetric carbamazepine immunoassay on two analyzers. To study the interference in presence of the analyte, aliquots of a serum pool prepared from patients receiving carbamazepine were further supplemented with various amounts of hydroxyzine and or cetirizine and apparent carbamazepine concentrations were measured again in order to compare with the value of original pool. No apparent carbamazepine concentration was observed when aliquots of drug‐free serum were supplemented with hydroxyzine or cetirizine. Moreover, in the carbamazepine pool, the original carbamazepine concentration compared well when aliquots of this serum pool were further supplemented with hydroxyzine or cetirizine. We conclude that the turbidimetric carbamazepine immunoassay is free from interference of hydroxyzine and cetirizine. J. Clin. Lab. Anal. 21:188–192, 2007. © 2007 Wiley‐Liss, Inc.

Keywords: hydroxyzine, cetirizine, carbamazepine, turbidimetric

REFERENCES

  • 1. Lanier B. Allergie rhinitis: selective comparison of the pharmaceutical options for management. Allergy Asthma Proc 2007;28:16–19. [DOI] [PubMed] [Google Scholar]
  • 2. Jauregui Presa I. H1 antihistamines: a review. Allergol Immunol Clin 2004;14:300–312. [Google Scholar]
  • 3. Morgan MW, Khan D, Nathan RA. Treatment for allergic rhinitis and chronic idiopathic urticaria: focus on oral antihistamines. Ann Pharmacother 2005;39:2056–2064. [DOI] [PubMed] [Google Scholar]
  • 4. Llorca PM, Spadone C, Sol O, et al. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3‐month double‐blind study. J Clin Psychiatry 2002;63:1020–1027. [DOI] [PubMed] [Google Scholar]
  • 5. Logothetis L, Mylonas IA, Baloyannis S, et al. A pilot open label clinical trial using hydroxyzine in multiple sclerosis. Int J Immunopathol Pharmacol 2005;18:771–778. [DOI] [PubMed] [Google Scholar]
  • 6. Maheshwari M, Padmini R. Role of Carbamazepine in reducing polypharmacy in epilepsy. Acta Neurol 1981;64:22–28. [DOI] [PubMed] [Google Scholar]
  • 7. Stein G. Drug treatment of personality disorder. Br J Psychiatry 1992;161:167–184. [DOI] [PubMed] [Google Scholar]
  • 8. El‐Desoky ES, AL‐Ghamdi HA, Halaby FH, AI‐Beshri M. Therapeutic monitoring of digoxin and antiepileptic drugs in Egypt and Saudi Arabia. Ther Drug Monit 2003;25:211–214. [DOI] [PubMed] [Google Scholar]
  • 9. Parant F, Moulsma M, Gagnieu MC, Lardet G. Hydroxyzine and metabolite as a source of interference in carbamazepine particle‐enhanced turbidimetric inhibition immunoassay (PENTINA). Ther Drug Monit 2005;27:457–462. [DOI] [PubMed] [Google Scholar]
  • 10. Miller JJ, Valdes R. Methods for calculating cross reactivity in immunoassays. J Clin Immunoassay 1992;15:97–100. [Google Scholar]
  • 11. Simons FE, Watson WT, Chen XY, Minuk GY, Simons KJ. The pharmacokinetics and pharmacodynamics of hydroxyzine in patients with primary biliary cirrhosis. J Clin Pharmacol 1989:29:809–815. [DOI] [PubMed] [Google Scholar]
  • 12. Johnson GR. A fatal case involving hydroxyzine. J Anal Toxicol 1982;6:69–70. [DOI] [PubMed] [Google Scholar]
  • 13. Magera BE, Betlach CJ, Sweatt AP, Derrick CW. Hydroxyzine intoxication in a 13 month old child. Pediatrics 1981;67:280–283. [PubMed] [Google Scholar]
  • 14. Ridout SM, Tariq SM. Cetirizine overdose in a young child. J Allergy Clin Immunol 1997;99:860–861. [DOI] [PubMed] [Google Scholar]
  • 15. Hermida J, Tutor JC. How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine 10, 11‐epoxide? Ther Drug Monit 2003;25:384–388. [DOI] [PubMed] [Google Scholar]
  • 16. Parant F, Bossu H, Gagnieu MC, Lardet G, Moulsma M. Cross‐reactivity assessment of carbamazepine 10, 11‐epoxide oxcarbazepine, and 10‐hydroxy‐carbazepine in two automated carbamazepine immunoassays: PENTINA and EMIT 2000. Ther Drug Monit 2003;25:41–45. [DOI] [PubMed] [Google Scholar]
  • 17. Dasgupta A, Datta P. Analytical performance evaluation of a new turbidimetric immunoassay for carbamazepine on the ADVIA 1650 analyzer: effect of carbamazepine 10, 11‐epoxide. Ther Drug Monit 2005;27:31–34. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES